AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vildasan-M Tablet

Prescription Icon
Prescription Required

Marketer

Sanrey Therapeutics

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildasan-M Tablet

Diabelite-Duo tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate severe diabetic complications like nephropathy and vision impairment, potentially lowering the risk of cardiovascular events. Diabelite-Duo may be used independently or in conjunction with other anti-diabetic therapies. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is personalized based on your health status, glycemic control, and concurrent medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical guidance. This treatment helps regulate blood sugar, preventing future complications. Continued commitment to your doctor's prescribed diet and exercise plan is crucial; lifestyle choices significantly influence diabetes management. Commonly reported adverse effects include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential risk, particularly when used with insulin or sulfonylureas; understanding its symptoms and management is vital. This medication isn't universally appropriate. Prior to commencing treatment, inform your physician of any history of renal, hepatic, or cardiac disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women require medical consultation before use. Drug interactions are possible; disclose all medications to your doctor to ensure safety. Alcohol should be minimized due to its hypoglycemic effect. Your physician will monitor renal function and blood glucose levels throughout the treatment period.

Primary Ingredients of Vildasan-M Tablet

No information provided. A rephrased version cannot be created.

Uses of Vildasan-M Tablet

Managing type 2 diabetes

Major Benefits of Vildasan-M Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vildasan-M Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Vildasan-M Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildasan-M Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Vildasan-M Tablet with a meal.

How Vildasan-M Tablet works:

Vildasan-M tablets contain a dual-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vildasan-M Tablet and alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vildasan-M Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Vildasan-M Tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when taking Vildasan-M Tablets, as dose modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Individuals with liver conditions should likely refrain from taking Vildasan-M tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Vildasan-M Tablet :

Should you forget a Vildasan-M Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vildasan-M Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vildasan-M Tablet

Vildasan-M Tablets rarely cause hypoglycemia by themselves; however, insufficient caloric intake while using this medication can lead to low blood sugar. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness may occur, particularly if meals are skipped or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Vildasan-M Tablets may cause nausea and vomiting. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Do not take other medications without consulting your doctor.
Vildasan-M Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication safely and ensure it remains inaccessible to children, pets, and others.
Vildasan-M Tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated in individuals under 18.
Vildasan-M Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Vildasan-M and seek immediate medical attention.
Prolonged Vildasan-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Vildasan-M Tablet is safe when used as directed by your doctor. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (especially if taking insulin or sulphonylurea) may occur. Report any persistent side effects to your physician.
Vildasan-M Tablet
86
MRP 100
14% off